Research Roundup

Debbie Rigby 05/03/2024

Debbie Rigby rounds up the latest in research news Treatment of obesity with medications binding the glucagon-like peptide 1 receptor The focus of this review is to elucidate the importance of glucagon-like peptide 1 (GLP-1) receptor-binding medications in addressing obesity-related health deteriorations. Higher doses of certain GLP-based drugs have shown superior effectiveness compared to lower

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

This web site is intended for Australian pharmacy professionals and is not a substitute for independent professional advice. Information and interactions contained in this website are for information purposes only and are not intended to be used to diagnose, treat, cure or prevent any disease. Further the accuracy, currency and completeness of the information available on this web site cannot be guaranteed. APPco Pty Ltd, its affiliates and their respective servants and agents do not accept any liability for any injury, loss or damage incurred by use of or reliance on the information made available via or through ajp.com.au whether arising from negligence or otherwise.

Research Roundup

Previous ‘An epic achievement.’

This is the most recent story.

MENU

ajp.com.au

Previous ‘An epic achievement.’

This is the most recent story.

MENU

ajp.com.au

Tags

Hi there! 👋 Looks like you’re not logged in.